C7H7BO3
149.94 g/mol
Pharmaceutical IntermediateWarning
1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-ol
CAS1187190-70-0
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
This compound is a benzoxaborole derivative that serves as a pharmaceutical intermediate. It is structurally related to ganfeborole, an experimental antibiotic under investigation for activity against Mycobacterium tuberculosis.
Pharmaceutical intermediate for benzoxaborole-based drug synthesisResearch compound for antibacterial studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1187190-70-0
Related Compounds
ReferenceSame Category
2-fluoro-N,N-dimethyl-4-nitro-benzamide
CAS1187368-66-6
pharmaceutical intermediate
ReferenceSame Category
4-Bromo-3,5-dichlorobenzotrifluoride
CAS118754-53-3
pharmaceutical intermediate
ReferenceSame Category
(R,S)-Montelukast Bis-sulfide
CAS1187586-58-8
pharmaceutical intermediate
ReferenceSame Category
2-(1-(Ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile
CAS1187594-13-3
pharmaceutical intermediate
Referencesame scaffold
Tavaborole
CAS174671-46-6
pharmaceutical raw material
Safety Reference
Warning
H315Causes skin irritation
H319Causes serious eye irritation
Identifiers
IUPAC Name
1-hydroxy-3H-2,1-benzoxaborol-5-ol
InChIKey
GEQGETTVGJBBOI-UHFFFAOYSA-N
SMILES
B1(C2=C(CO1)C=C(C=C2)O)O
Synonyms (7)
—